Early development of clevudine resistance during clevudine therapy in a patient with chronic hepatitis B who received prior lamivudine therapy.
Kim
Yun Soo
YS
Kim
Geum-Ha
GH
Hwang
You-Jin
YJ
Kwon
Oh Sang
OS
Choi
Duck Joo
DJ
Kim
Ju Hyun
JH
D000225:Adenine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D001086:Arabinofuranosyluracil / Q000031:analogs & derivatives* / Q000627:therapeutic use; D024882:Drug Resistance, Viral / Q000235:genetics*; D006515:Hepatitis B virus / Q000187:drug effects / Q000235:genetics*; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D020125:Mutation, Missense / Q000235:genetics; D063065:Organophosphonates / Q000494:pharmacology / Q000627:therapeutic use*; D017422:Sequence Analysis, DNA
D000998:Antiviral Agents; D063065:Organophosphonates; D019259:Lamivudine; D001086:Arabinofuranosyluracil; C053001:adefovir; C034935:clevudine; D000225:Adenine